Plasma Proteomic Profiling Discovers Molecular Features Associated with Upper Tract Urothelial Carcinoma.
Yuanyuan Qu,Zhenmei Yao,Ning Xu,Guohai Shi,Jiaqi Su,Shiqi Ye,Kun Chang,Kai Li,Yunzhi Wang,Subei Tan,Xiaoru Pei,Yijiao Chen,Zhaoyu Qin,Jinwen Feng,Jiacheng Lv,Jiajun Zhu,Fahan Ma,Shaoshuai Tang,Wenhao Xu,Xi Tian,Aihetaimujiang Anwaier,Sha Tian,Wenbo Xu,Xinqiang Wu,Shuxuan Zhu,Yu Zhu,Dalong Cao,Menghong Sun,Hualei Gan,Jianyuan Zhao,Hailiang Zhang,Dingwei Ye,Chen Ding
DOI: https://doi.org/10.1016/j.xcrm.2023.101166
IF: 16.988
2023-01-01
Cell Reports Medicine
Abstract:Upper tract urothelial carcinoma (UTUC) is often diagnosed late and exhibits poor prognosis. Limited data are available on potential non-invasive biomarkers for disease monitoring. Here, we investigate the proteomic profile of plasma in 362 UTUC patients and 239 healthy controls. We present an integrated tissue-plasma proteomic approach to infer the signature proteins for identifying patients with muscle-invasive UTUC. We discover a protein panel that reflects lymph node metastasis, which is of interest in identifying UTUC patients with high risk and poor prognosis. We also identify a ten-protein classifier and establish a progression clock predicting progression-free survival of UTUC patients. Finally, we further validate the signature proteins by parallel reaction monitoring assay in an independent cohort. Collectively, this study portrays the plasma proteomic landscape of a UTUC cohort and provides a valuable resource for further biological and diagnostic research in UTUC.